Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT02160366

Conditions

Advanced Cancers

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Biomarker Research

Study Details

Brief summary:

The goal of this laboratory research study is to collect and analyze treatment, molecular profiling and biomarker data. The results of the data analysis will be used to better understand how to characterize tumors and identify therapies that may be tailored to individual patients and to identify and/or predict side effects that may occur and/or predict which therapies may be best for participants. Research may also be done on your existing tissue to identify new biomarkers.

Conditions

Advanced Cancers

Study ID

NCT02160366

Start date

Sep 27, 2010

Status verified date

Jan, 2020

Completion date

Sep 27, 2020

Anticipated

Primary completion date

Sep 27, 2020

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. All patients referred to the Clinical Center for Targeted Therapy are potentially eligible for recruitment.

Exclusion Criteria:

n/a

Study Design

Enrollment

2000 participants

Anticipated

Interventions and Outcome Measures

Arms

Biomarker/Molecular Data Collection and Analyzation

Advanced cancer participants

Interventions

Biomarker Research

Research studies on new biomarkers conducted on previously banked blood and/or tumor tissue. Samples collected may include blood, fresh tumor tissue, urine, saliva, bone marrow, pleural fluid, ascites, skin or hair follicle.

Primary outcome measure

  • Comparison of Biomarker Profiling to Treatment Outcome [ Time Frame: 2 months ]

Central Contacts and Locations

Central contacts

Filip Janku, MD, PHD

713-563-1930fjanku@mdanderson.org

Locations

University of Texas MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jan 10, 2020

Last verified

Jan, 2020

Keywords

  • Advanced Cancers
  • Molecular profiling
  • Biomarker data
  • Data analysis
  • Tumor marker

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2020-01-10.